| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700757 | European Journal of Surgical Oncology (EJSO) | 2017 | 10 Pages |
Abstract
PM develop in approximately a fourth of patients undergoing CRS/IPC for CRC. Of these, about 1/3 may be eligible for PLAT. PLAT is a valuable treatment option providing good local control and potentially prolongation of overall survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T.A. Bin Traiki, O.M. Fisher, S.J. Valle, R.N. Parikh, M.A. Kozman, D. Glenn, M. Power, W. Liauw, N.A. Alzahrani, D.L. Morris,